Pharma Marketing Network

DECEMBER 4, 2024

Marketing pharma has become a complex and competitive field, with companies vying for the attention of healthcare providers (HCPs), patients, and regulators alike. With the right strategies, you can rise above the competition and drive measurable success. The good news? For tips on navigating regulations, visit Pharma Marketing.

Competition 52

Competition Marketing Pharma Media 52

European Pharmaceutical Review

JULY 4, 2024

In the US, botanical dietary supplements can be sold without US Food and Drug Administration (FDA) approval, 1 prompting many vendors to promote the use of botanical products as dietary supplements , 2 rather than pursue a path of regulatory approval. 3 Is two too few? 3 Is two too few?

Marketing 103

Marketing Food and Drug Administration Medicine Prescription 103

Pharma Marketing Network

MARCH 10, 2025

Google Ads requires pre-approval for prescription drug promotions, while platforms like TikTok prohibit pharma ads entirely. Pharma brands that understand platform policies, create compelling yet compliant content, and continuously optimize performance can achieve strong results in this competitive digital landscape. In the U.S.,

Media 52

Media Pharma Marketing Healthcare 52

PM360

NOVEMBER 29, 2022

When developing content for new drug labels, life sciences companies’ regulatory teams face challenges in gathering intelligence to better understand competitive factors, market dynamics, and effective approval strategies. Food and Drug Administration (FDA) or European Medicines Agency (EMA). Challenges in Working with Label Data.

Food and Drug Administration 98

Food and Drug Administration Competition Safety Pharmacology 98

Pharma Marketing Network

MARCH 13, 2025

As competition in the healthcare space intensifies, pharma brands that fail to integrate AI risk falling behind. Optimize inventory management based on prescription trends. FDA guidelines on AI-generated content. Can AI help with FDA compliance in pharma marketing? Overcoming Challenges in AI Adoption 1.

Marketing 52

Marketing Pharma Medical Ethics 52

Legacy MEDSearch

MARCH 7, 2024

Food and Drug Administration (FDA) announced the clearance of Dexcom’s device, marking it as the first continuous glucose monitor available over the counter. Dexcom disclosed its plans to make Stelo available for purchase online without the need for a prescription, starting in summer 2024. On March 5, the U.S. Are you hiring?

Food and Drug Administration 52

Food and Drug Administration FDA Food Management 52

European Pharmaceutical Review

NOVEMBER 8, 2022

In the current US Congressional session, Congress has focused heavily on legislation directed at reducing prescription drug prices. Citizen Petitions before the FDA. 2 Submission of a Citizen Petition to the FDA obligates the regulator to address the arguments raised. 5) monitoring access to biosimilars. Senate Bill 562 (S.

Food and Drug Administration 52

Food and Drug Administration Pharma Manufacturing Prescription 52

Clarivate

JULY 5, 2023

The month of July could see seven FDA-approved adalimumab biosimilars launch in the United States, an unprecedented situation for a market that has been relatively slow to embrace biosimilars. The Biosimilars Forum has hailed 2022 as a watershed year that could create a more competitive U.S. from 91% in 2023 to 36% by 2031.

Marketing 97

Marketing Physicians Manufacturing Competition 97

pharmaphorum

JANUARY 9, 2023

China still hasn’t approved western mRNA vaccines, despite submission, and the US FDA rejects Chinese-only trial data for cancer medicines. The innovative prescription medicine industry faces a trifecta of challenges. Pharma boxed in? Strategic choice challenges for 2023. In reality, the first two options have very limited potential.

Medicine 98

Medicine Healthcare Healthcare Pharma 98

Nixon Gwilt Law

JUNE 24, 2024

Companies that proactively address these aspects create a foundation for sustainable growth and competitive advantage in the digital health ecosystem. Instead of limiting themselves under a prescription-based model, founders should explore alternative revenue streams.

FDA 52

FDA Education Healthcare Healthcare 52

PM360

SEPTEMBER 21, 2023

Attention deficit hyperactivity disorder (ADHD) drug Vyvanse (lisdexamfetamine dimesylate) , manufactured by Takeda, also is facing generic competition. In the respiratory area with inhalers, it’s tough to get drugs approved, so the competition comes slowly,” he said.

Management 105

Management Manufacturing Sales Competition 105

Pharma Marketing Network

FEBRUARY 27, 2025

Heres how programmatic display ads provide a competitive edge: 1. This is especially critical for high-cost prescription drugs like Keytruda or Ozempic , where each impression needs to count. Compliance-Ready Advertising Pharma marketers must ensure their campaigns adhere to FDA and HIPAA regulations while still being effective.

Pharma 52

Pharma Prescription CRM Marketing 52

European Pharmaceutical Review

AUGUST 22, 2022

1 This has led to a great deal of pre-competitive data sharing. As the data is anonymised it will not be possible to select excipient suppliers based on lowest available nitrite levels, but it may prompt some suppliers to publish this information as it could provide a competitive advantage. ng/day for novel API nitrosamines.

Food and Drug Administration 59

Food and Drug Administration Prescription Food Medicine 59

Nixon Gwilt Law

JUNE 24, 2024

Companies that proactively address these aspects create a foundation for sustainable growth and competitive advantage in the digital health ecosystem. Instead of limiting themselves under a prescription-based model, founders should explore alternative revenue streams.

FDA 52

FDA Education Healthcare Provider Patients 52

Pharma Marketing Network

MARCH 3, 2025

By refining user experience, messaging, and engagement strategies, pharma companies can increase prescription intent, patient adherence, and HCP interaction rates. CRO helps maximize engagement by ensuring that HCPs and patients take action rather than just browsing, ultimately improving prescription intent and adherence.

Pharma 52

Pharma Patients Prescription Medical 52

Pharmaceutical Representative Training

JANUARY 29, 2025

These high prices are the result of multiple factors: theyre derived from living organisms making them sensitive and complex for both manufacturers and patients, research requires advanced technology to test for safety and effectiveness, and theyre in high demand without much competition. The Cost-Saving Alternative: What are Biosimilars?

Marketing 52

Marketing Healthcare Healthcare Physicians 52

Pharma Marketing Network

JANUARY 29, 2025

AI-driven tools can: Analyze patient insights to tailor drug promotions Enhance HCP-targeted marketing using behavioral data Automate regulatory compliance monitoring Improve sales force effectiveness with AI-generated recommendations Marketers who embrace AI will gain a competitive edge in an industry where precision and speed define success.

Marketing 52

Marketing Pharma Pharmaceutical Ethics 52

MedReps

JANUARY 30, 2023

If you know how to prepare and get ahead of your competition, reaching your goals will be that much easier. As they live longer, there’s more of a need for prescription medications that treat their health issues, as well as supplies like walkers and wheelchairs that help them get around.

Medical sales 74

Medical sales Medical Sales Sales goal 74

Pharmaceutical Technology

OCTOBER 25, 2022

Understanding both the significant competitive advantages that FDC products can offer, and the difficulties and potential pitfalls associated with development and manufacturing of FDC drugs in oral solid dosage forms is a critical first step for companies exploring this approach. Pharmaceutical companies – and the FDA – are embracing FDCs.

Manufacturing 52

Manufacturing Physicians Prescription Pharmaceutical 52

Pharma Marketing Network

FEBRUARY 27, 2025

The ability to target based on demographics, interests, location, and behavior makes PPC a game-changer for pharma brands promoting prescription drugs, disease awareness, and patient education resources. Why PPC is Essential for Pharma Marketing The pharma industry operates in a highly regulated and competitive space.

Pharma 52

Pharma Marketing Networking Prescription 52

Pharmaceutical Representative Training

DECEMBER 28, 2021

Before 2020, the landscape of drug marketing involved following drug approvals by the Food and Drug Administration ( FDA ), finding which patient population would benefit from therapy, and visiting specialized doctors in-person to advertise its advantages compared to current guidelines.

Marketing 52

Marketing Food and Drug Administration Pharma Doctors 52

pharmaphorum

JUNE 29, 2022

The prescription medicine market has recovered from the wild swings of the early pandemic with renewed growth. Non-COVID prescription medicines didn’t stop launching during the pandemic — approvals by both the FDA and the EMA were, in fact historically high in both 2020 and 2021. The scope of the problem.

Doctors 59

Doctors Medicine Marketing Sales 59

Silver Line CRM

NOVEMBER 11, 2020

But today, the need to satisfy patients, providers, payers, regulatory agencies, and shareholders alike — while staying ahead of the competition — takes the right technologies at the right time. . But as we move forward into the next decade, they’ve gone from “nice to have” options to requirements to stay competitive. Brand tracking.

Marketing 52

Marketing Pharmaceutical Side effects Insurance 52

PM360

NOVEMBER 21, 2024

Adam with his family Greatest Achievements and Activism Adam said his greatest professional achievement is the launch of Keytruda, a prescription immunotherapy drug used to treat many types of cancer, which Merck manufactures and sells. Food and Drug Administration (FDA) approval. It was the first PD-1 inhibitor to receive U.S.

Ethics 59

Ethics Food and Drug Administration Marketing Healthcare 59

Evolve Your Success

OCTOBER 3, 2023

Also, I work with pharmaceutical reps to see what physicians they’re working with who are writing certain prescriptions for patients. I know that if they’re writing this prescription or giving this type of treatment, they’re going to want to hear about my testing. What does the competition look like in this space?

Sales 162

Sales Medical sales Physicians Patients 162

Nixon Gwilt Law

JANUARY 16, 2024

Companies will also need to understand whether the FDA will consider their model to be software as a medical device (SaMD) that is subject to the FD&C Act. Rebecca says, “ New and existing companies will offer GLP-1 prescriptions for weight loss. The field is already saturated, so we will see companies exit as leaders emerge.

Healthcare 52

Healthcare Healthcare Management Insurance 52

Nixon Gwilt Law

JANUARY 16, 2024

Companies will also need to understand whether the FDA will consider their model to be software as a medical device (SaMD) that is subject to the FD&C Act. Rebecca says, “ New and existing companies will offer GLP-1 prescriptions for weight loss. The field is already saturated, so we will see companies exit as leaders emerge.

Healthcare 52

Healthcare Healthcare Management Insurance 52

Evolve Your Success

JANUARY 31, 2023

A lot of organizations that may have a sales model don’t probably follow the prescription that we deliver or the method that we deliver to them, which is why they contract us. You have to be able to talk about your product, especially in our field because it’s so governed by the FDA. That is true. It’s litigious.

Medical sales 162

Medical sales Sales Medical Training 162

Contrarian Sales Techniques

DECEMBER 5, 2023

Regulation changes, like the introduction of the Prescription Drug Marketing Act in the 1980s, brought about a more structured approach. Keeping abreast of the latest regulations, like FDA approvals and industry guidelines, ensures that you're not just a salesperson, but a trusted advisor to your clients.

Pharmaceutical Sales 52

Pharmaceutical Sales Training Sales Pharmaceutical 52

Cadensee

JULY 20, 2021

So, you see on one side, there's a special body of the FDA trying to listen to patients to find new targets for health and for pharmaceutical technology. But in terms of Israel as a competitive advantage, I think data is much more than just good technology. When do you think it is the most important? I've been preaching for that.

Food and Drug Administration 52

Food and Drug Administration Doctors Healthcare Healthcare 52

Pharmaceutical Technology

MAY 31, 2023

The US Food and Drug Administration (FDA) has proposed a new model for prescription medication guides for brand name and generic drugs, to increase accessibility and reduce medication nonadherence. The FDA said that the proposed revamp should help limit preventable adverse drug reactions and improve health outcomes.

Prescription 52

Prescription FDA Food and Drug Administration Medical 52

Pharmaceutical Technology

MAY 12, 2023

As the next step in the FDA’s efforts to reduce prescription drug deaths , the agency is requiring updates to the boxed warning and other information for attention deficit hyperactivity disorder (ADHD) prescription stimulants. Prescription stimulants are used to treat ADHD, narcolepsy, and binge-eating disorder.

FDA 59

FDA Prescription Patients Medical 59

Pharmaceutical Technology

MAY 4, 2023

After a winter marked by a rise in hospitalisations due to the RSV, the FDA has granted its first approval for an Respiratory Syncytial Virus (RSV) vaccine to GSK’s Arexvy for adults ages 60 years and above. These recommendations and the FDA approval were based on positive AReSVi-006 Phase III trial data.

FDA 64

FDA Safety Medicine Prescription 64

Pharmaceutical Technology

MAY 26, 2023

The FDA has flagged this issue as pharmacies selling prescription drugs illegally have proliferated over the years. The US Food and Drug Administration (FDA commissioner Dr. Robert Califf says, “The illegal sale of prescription drug stimulants online puts Americans at risk and contributes to potential abuse, misuse, and overdose.”

Food and Drug Administration 52

Food and Drug Administration Prescription FDA Medical 52

Pharmaceutical Technology

MAY 15, 2023

If approved, the therapy could become the first FDA-approved gene transfer therapy for the condition. The FDA will assess the drug’s approval before its Prescription Drug User Fee Act (PDUFA) date on 29 May 2023. She said, “I wish the data were more persuasive”.

FDA 52

FDA Food and Drug Administration Prescription Prospecting 52

Pharmaceutical Technology

MAY 9, 2023

New York-based Eyenovia has announced an FDA approval for Mydcombi (tropicamide and phenylephrine hydrochloride), the first ophthalmic spray for mydriasis or pupil dilation. The spray can be used for diagnostic procedures and conditions where short-term pupil dilation is necessary, such as cataract surgery or corrective prescriptions.

FDA 52

FDA Prescription Prospecting Medical 52

Pharmaceutical Technology

APRIL 21, 2023

The US Drug Enforcement Agency (DEA) will hold the 24th National Prescription Drug Take Back Day to gather unwanted, old or expired medication for safe disposal , on April 22. According to the agency’s website, this event aims to prevent the circulation of unused prescription drugs that could potentially harm American citizens.

Prescription 52

Prescription Medical Specialization Prospecting 52